Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2017.05.005PMID 28506769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Society of Clinical Oncology

  2020influential reference
• Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature

  2017cited by this paper
• Additional file 5: Figure S15â S17. of The Sinocyclocheilus cavefish genome provides insights into cave adaptation

  2016cited by this paper
• Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others.

  2016cited by this paper
• THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer

  2016influential reference
• Epigenetic Biomarkers in Colorectal Cancer

  2016influential reference
• Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality.

  2016influential reference
• Cancer statistics, 2016

  2016cited by this paper
• Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer

  2016cited by this paper
• DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

  2016influential reference
• The evolving role of microsatellite instability in colorectal cancer: A review.

  2016cited by this paper
• Modulation of the human gut microbiota by dietary fibres occurs at the species level

  2016cited by this paper
• The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

  2015cited by this paper
• Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis

  2015cited by this paper
• Regional alcohol consumption and alcohol-related mortality in Great Britain: novel insights using retail sales data

  2015cited by this paper
• Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

  2015cited by this paper
• MiR-320e is a novel prognostic biomarker in colorectal cancer

  2015cited by this paper
• Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial

  2015cited by this paper
• Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer.

  2015cited by this paper
• Colorectal Cancer Biomarkers: Where Are We Now?

  2015influential reference
• The expression and clinical significance of microRNAs in colorectal cancer detecting

  2015cited by this paper
• Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.

  2015cited by this paper
• Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

  2015cited by this paper
• MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer

  2015influential reference
• New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA

  2014cited by this paper
• Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

  2014cited by this paper
• Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer

  2014influential reference
• DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

  2014cited by this paper
• COLORECTAL CANCER, NOVEL BIOMARKERS AND IMMUNOHISTOCHEMISTRY - AN OVERVIEW

  2014cited by this paper
• FOLFIRI with cetuximab or bevacizumab: FIRE-3-authors' reply.

  2014influential reference
• Prognostic significance of KRAS gene mutations in colorectal cancer - preliminary study

  2014cited by this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cited by this paper
• Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis

  2014cited by this paper
• Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma

  2014influential reference
• DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer

  2013cited by this paper
• APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis.

  2013cited by this paper
• Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

  2013cited by this paper
• Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance

  2013cited by this paper
• Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

  2013cited by this paper
• Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.

  2013influential reference
• Epigenetics and Colorectal Cancer Pathogenesis

  2013influential reference
• Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer

  2013cited by this paper
• Whole-genome methylation analysis of benign and malignant colorectal tumours

  2013influential reference
• Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis

  2013cited by this paper
• Complications of Colonoscopy

  2013cited by this paper
• TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression

  2013cited by this paper
• Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.

  2013cited by this paper
• Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

  2012cited by this paper
• Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Microsatellite instability--MSI markers (BAT26, BAT25, D2S123, D5S346, D17S250) in rectal cancer.

  2012influential reference
• Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

  2012cited by this paper
• Detection of HNA‐3a and ‐3b antibodies using transfected cell lines and recombinant proteins

  2012cited by this paper
• BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis

  2012cited by this paper
• DNA methylation biomarker candidates for early detection of colon cancer

  2012cited by this paper
• Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

  2012cited by this paper
• Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients

  2011cited by this paper
• Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta‐analysis

  2011influential reference
• Cloning and Characterization of the ζ-Carotene Desaturase Gene from Chlorella protothecoides CS-41

  2011cited by this paper
• Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

  2011cited by this paper
• Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer

  2011cited by this paper
• Microsatellite instability and colorectal cancer.

  2011cited by this paper
• Fecal Tests: From Blood to Molecular Markers

  2011cited by this paper
• Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer

  2011influential reference
• Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

  2011cited by this paper
• Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer

  2011cited by this paper
• Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

  2011cited by this paper
• Epigenetics and colorectal cancer

  2011cited by this paper
• Complications of colonoscopy.

  2011cited by this paper
• Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

  2011influential reference
• Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

  2011cited by this paper
• Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

  2011cited by this paper
• Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

  2011cited by this paper
• Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

  2010cited by this paper
• Clinical relevance of microsatellite instability in colorectal cancer.

  2010cited by this paper
• Molecular basis of colorectal cancer.

  2010cited by this paper
• KRAS mutational analysis for colorectal cancer

  2010cited by this paper
• Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

  2010cited by this paper
• Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations.

  2010cited by this paper
• Microsatellite instability in colorectal cancer—the stable evidence

  2010influential reference
• Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

  2010cited by this paper
• Colorectal cancer

  2010cited by this paper
• Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening

  2010cited by this paper
• MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening

  2010cited by this paper
• Clinicopathological and protein characterization of BRAF‐ and K‐RAS‐mutated colorectal cancer and implications for prognosis

  2010cited by this paper
• Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• 2C or not 2C: a closer look at cell nuclei and their DNA content

  2009cited by this paper
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

  2009cited by this paper
• Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

  2009cited by this paper
• GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer

  2009cited by this paper
• N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

  2009cited by this paper
• Stage-specific prognostic value of molecular markers in colon cancer: Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60-00 trial.

  2009cited by this paper
• Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.

  2009influential reference
• Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

  2009cited by this paper
• Complete deletion of Apc results in severe polyposis in mice

  2009cited by this paper
• Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

  2009cited by this paper
• American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

  2009cited by this paper

• Two decades of artificial intelligence in colon cancer diagnosis and treatment: a bibliometric analysis of research trends (2003–2023)

  2026influential citation
• A panel of plasma proteins associated with venous thromboembolism in patients with prostate cancer

  2025cites this paper
• Ultrasensitive rapid quantitative CRISPR-based detection of cervical cancer tumor marker proteins SCCA and CEA

  2025cites this paper
• A Four-Gene Panel in Rectal Swab Samples as a Biomarker for Colorectal Cancer Screening

  2024cites this paper
• Unlocking the potential of Escherichia coli K-12: A novel approach for malignancy reduction in colorectal cancer through gene expression modulation.

  2024cites this paper
• Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study

  2024cites this paper
• Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics

  2024cites this paper
• CRIS: Collaborative Refinement Integrated with Segmentation for Polyp Segmentation

  2024cites this paper
• Nursing Informatics and Epigenetics: Methodological Considerations for Big Data Analysis

  2023cites this paper
• Characterisation of Colorectal Cancer Cell Lines through Proteomic Profiling of Their Extracellular Vesicles

  2023cites this paper
• Diagnostic Value of Inflammation-Related Indicators in Distinguishing Early Colon Cancer and Adenomatous Polyps

  2023cites this paper
• Antibody-Loaded Nanoplatforms for Colorectal Cancer Diagnosis and Treatment: An Update

  2023cites this paper
• Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia.

  2022cites this paper
• World Journal of Gastroenterology Inflammation, microbiome and colorectal cancer disparity in African-Americans: Are there bugs in the genetics? based on for

  2022cites this paper
• Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis

  2022cites this paper
• Association of has_circ_0001944 upregulations with prognosis and cancer progression in patients with colorectal cancer

  2022cites this paper
• Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy

  2022cites this paper
• LINC 01436 is overexpressed in colorectal cancer and promotes cancer cell proliferation by suppressing tumor-suppressive miR-466 maturation

  2022cites this paper
• Classification of the Confocal Microscopy Images of Colorectal Tumor and Inflammatory Colitis Mucosa Tissue Using Deep Learning

  2022cites this paper
• Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players.

  2022cites this paper
• Diagnostic value of long noncoding RNA LINC01485 in patients with colorectal cancer.

  2022cites this paper
• Carbon nanomaterials-based electrochemical cancer biomarkers biosensors

  2022cites this paper
• B7-H3: A Useful Emerging Diagnostic Marker for Colon Cancer

  2022cites this paper
• The implication of molecular markers in the early stage diagnosis of colorectal cancers and precancerous lesions

  2022cites this paper
• Electrochemical biosensors for measurement of colorectal cancer biomarkers

  2021cites this paper
• Development and validation of magnetic resonance imaging-based radiomics models for preoperative prediction of microsatellite instability in rectal cancer

  2021influential citation
• Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer

  2021cites this paper
• Faecal microbial biomarkers in early diagnosis of colorectal cancer

  2021cites this paper
• CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review

  2021cites this paper
• Recent advances in fecal gene detection for colorectal cancer diagnosis.

  2021cites this paper
• Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review

  2021cites this paper
• Nanocarriers as a Tool for the Treatment of Colorectal Cancer

  2021cites this paper
• LINC 01436 is Overexpressed in Colorectal Cancer and Promotes Cancer Cell Proliferation by Suppressing the Maturation of Tumor Suppressive miR-466

  2021cites this paper
• The Function and Prognostic Value of RNA-Binding Proteins in Colorectal Adenocarcinoma Were Analyzed Based on Bioinformatics of Smart Medical Big Data

  2021cites this paper
• Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer

  2021cites this paper
• Quantitative detection of circulating MT-ND1 as a potential biomarker for colorectal cancer

  2021cites this paper
• Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics

  2021cites this paper
• Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.

  2021cites this paper
• Radiomics, aptamers and nanobodies: New insights in cancer diagnostics and imaging

  2021cites this paper
• Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.

  2020cites this paper
• Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer

  2020cites this paper
• m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation

  2020cites this paper
• Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning

  2020cites this paper
• DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples

  2020cites this paper
• lncRNA UASR1 sponges miR-107 in colorectal cancer to upregulate oncogenic CDK8 and promote cell proliferation

  2020cites this paper
• Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer

  2020cites this paper
• The simultaneous detection of the squamous cell carcinoma antigen and cancer antigen 125 in the cervical cancer serum using nano-Ag polydopamine nanospheres in an SERS-based lateral flow immunoassay

  2020cites this paper
• A flux-adaptable pump-free microfluidics-based self-contained platform for multiplex cancer biomarker detection.

  2020cites this paper
• IMMUNOHISTOCHEMICAL EXPRESSION OF TLR4, MYD88 AND PCNA IN COLON POLYPS OF OVARIECTOMIZED FEMALE RAT INDUCTION BY AZOXY METHANE AND TREATED BY ESTROGEN HORMONE

  2020cites this paper
• Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria

  2019cites this paper
• A Summary of the Main Biomarkers for Diagnosis and Prognosis of Sporadic Colorectal Cancer: A Review

  2019influential citation
• High expression of nucleophosmin is closely related to the grade and invasion of colorectal cancer

  2019cites this paper
• RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway

  2019cites this paper
• Expression and Clinical Significance of POLR1D in Colorectal Cancer

  2019cites this paper
• Relationships between adherence to the Mediterranean diet and methylation of WNT pathway-related genes implicated in colorectal cancer

  2019influential citation
• A Novel Prognostic DNA Methylation Panel for Colorectal Cancer

  2019cites this paper
• Two Novel Long Noncoding RNAs – RP11-296E3.2 and LEF1-AS1can – Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer

  2019cites this paper
• Long-Chain Noncoding RNA PVT1 Gene Polymorphisms Are Associated with the Risk and Prognosis of Colorectal Cancer in the Han Chinese Population

  2019cites this paper
• The Correlation of KRAS Gene Expression and P53 Immunoexpression in Colorectal Adenocarcinoma

  2019cites this paper
• High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer.

  2019cites this paper
• Association of a New Germline Variant in the MUTYH DNA Glycosylase Gene with Colorectal Adenoma Transformation into Malignancy

  2019cites this paper
• The identification of a common different gene expression signature in patients with colorectal cancer.

  2019cites this paper
• Mutation analysis of POLE gene in patients with early-onset colorectal cancer revealed a rare silent variant within the endonuclease domain with potential effect on splicing

  2019cites this paper
• Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.

  2019cites this paper
• Enzyme-free multicolor biosensor based on Cu2+-modified carbon nitride nanosheets and gold nanobipyramids for sensitive detection of neuron specific enolase

  2019cites this paper
• Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study

  2019cites this paper
• Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study.

  2019cites this paper
• The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis

  2019cites this paper
• GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.

  2018cites this paper
• Mathematical Modeling and Computational Simulation of the Diffusive Behavior of Adenocarcinoma Biomarker Particles

  2018cites this paper
• Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis

  2018cites this paper
• Clinical outcomes of endoscopic resection for colorectal laterally spreading tumors with advanced histology

  2018cites this paper
• Early Epigenetic Markers for Precision Medicine.

  2018cites this paper
• Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis

  2018cites this paper
• Polypeptide ‐ GalNAc ‐ T 6 expression predicts better overall survival in patients with colon cancer

  2018cites this paper
• Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer

  2018cites this paper
• Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.

  2018cites this paper
• A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation

  2018cites this paper
• Relationship between CT signs and the expression of miR-146a in colon cancer

  2018cites this paper
• Exosomes and their importance in metastasis, diagnosis, and therapy of colorectal cancer

  2018cites this paper
• Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy

  2017cites this paper
• Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID)

  2017cites this paper
• Carbon nanotubes-based electrochemical (bio)sensors for biomarkers

  2017cites this paper
• Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review

  2017cites this paper
• Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy

  2017cites this paper
• Long non-coding RNA DLEU 7-AS 1 promotes the occurrence and development of colorectal cancer via Wnt / β-catenin pathway

  year unknowncites this paper